With a one year PEG ratio of 3,705.4, Inovalon Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 98.84% of US stocks.
Inovalon Holdings Inc's stock had its IPO on February 12, 2015, making it an older stock than just 20.63% of US equities in our set.
With a price/earnings ratio of 508.2, Inovalon Holdings Inc P/E ratio is greater than that of about 98.21% of stocks in our set with positive earnings.
If you're looking for stocks that are quantitatively similar to Inovalon Holdings Inc, a group of peers worth examining would be ROG, OSPN, EVI, KTOS, and KWR.
Inovalon Holdings provides advanced cloud-based data analytics and data-driven intervention platforms to the healthcare industry in the United States. The company was founded in 1998 and is based in Bowie, Maryland.
INOV Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for INOV, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Inovalon Holdings Inc ranked in the 16th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Inovalon Holdings Inc, consider:
In the past 5.58 years, Inovalon Holdings Inc has a compound free cash flow growth rate of 0.03%; that's higher than only 21.74% of free cash flow generating stocks in the Technology sector.
Inovalon Holdings Inc's weighted average cost of capital (WACC) is 9%; for context, that number is higher than 67.16% of tickers in our DCF set.
Inovalon Holdings Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as INOV, try CNXN, VPG, ZIXI, EPAY, and HBB.
Investors do not wait. Get ready for Active Management now! Now is the time for investors to incorporate quantitative tools to empower their portfolio management. Any change in the direction of any of the principal components of earnings growth such as sales growth, gross margins, operating or financing costs, may be important indicators about future direction […] The post Inovalon Holdings: Resilient Growth Within Healthcare appeared first on ValueWalk .
Retailer’s Specialty Pharmacy Business to Implement ScriptMed® Cloud Solution to Empower Enhanced Outcomes and Economics for its CustomersBOWIE, Md., July 23, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced a long-term engagement with Walmart’s Specialty Pharmacy business (NYSE: WMT) to provide cloud-based capabilities through the Inovalon ONE® Platform as part of its data-driven strategy to improve outcomes and economics for its customers. The high-complexity and high-cost nature of specialty pharmacy stands to benefit significantly from the capabilities enabled through the Inovalon ONE® Platform. Through the implementation of ScriptMed® Cloud, a software-as-a-service (SaaS) cloud offering...